Badania i artykuły

Badania kliniczne wykazały, że leczenie ozonem wykazuje korzyści terapeutyczne, w takich chorobach, jak:

  1. Zapalenie szpiku, ropniak opłucnej, ropnie, przetoki z zakażonych ran, wrzody przez ciśnienie, przewlekłych owrzodzeń stopy cukrzycowej, i Burns (Payr 1935; Aubourg, 1940; Rokitansky, 1982; Miroshin i Kontorshikova, 1995; Werkmeister, 1995; Shaschova et al., 1995; Filippi i Kirschner, 1995; Wasser, 1995a; Bulinin et al., 1995; Kudravcev et al., 1995; Kasumjan et al. 1995; Steinhart et al., 1999; Valacchi i wsp., 2005; Travagli i inni, 2009a.; Menendez i wsp., 2010).
  2. Starcze zwyrodnienie plamki żółtej (forma zanikowe), ponieważ nie okulistyki liczyć na znacznej obróbce jeszcze (Riva Sanseverino et al., 1990; Bocci, 2002; Borrelli i Bocci, 2013).
  3. Choroby neurodegeneracyjne, takie jak: o zaburzenia nerwu wzrokowego, zapalenie siatkówki barwnikowa, otwartego kąta pierwotna jaskra, starcze demencje tym Choroba Alzheimera, choroba niedokrwienna naczyń mózgowych-ślimakowy zespół przedsionkowy, inne (Rodriguez, Garcia i wsp 1998;. Rodriguez, Menéndez, Devesa i wsp. 1998; Rodríguez, Menéndez, Garcia i wsp. 1998; Copello et al., 2003; Copello et al. 2013).
  4. Zwyrodnieniowe i zapalne schorzenia ortopedyczne (choroba zwyrodnieniowa stawów, etc) (Riva Sanseverino, 1989; Verga, 1989; Siemsen, 1995; Bocci i wsp., 2000; Jucopilla et al., 2000; Aleksander i współpracownicy, 2000. 2002; Bonetti et al., 2001; Fabris et al. 2001; Petralia et al., 2001; Tabaracci, 2001; Andreula et al., 2003).
  5. Zespół przewlekłego zmęczenia i fibromialgią (Cosentino et al, 2000;. Loconte, 2000; Borrelli i Bocci, 2002; Hidalgo-Tallon i wsp., 2012).
  6. Zaawansowane choroby niedokrwienne (niedokrwienie kończyn dolnych i serca, następstwa mózgowy i sercowych wypadków naczyniowych, a także ewentualnie serca Atak gdy pacjenci zbyt późno dla trombolizy) (Rokitansky, 1981, 1982; Romero i in., 1988; Amato, 2000; Giunta et al, 2001;.. Tylicki et al, 2001, 2003, 2004a, b; Biedunkiewicz et al., 2004; Di Paolo i wsp., 2005; Clavo i wsp., 2011).
  7. Przewlekłe i nawracające infekcje w jamie ustnej (Lynch, 2004).
  8. Ostre i przewlekłe choroby zakaźne, zwłaszcza o podłożu bakteryjnym, wirusowym czy wywoływane przez grzyby, odporne na działanie antybiotyków ( borelioza, zapalenie wątroby, HIV, AIDS, zakażenia opryszczkowe i półpasiec, zakażenia przez wirusa brodawczaka, grzybica paznokci, kandydoza, giardiasis i cryptosporidiosis) -  (Mattassi et al, 1985;. Bocci i Paulesu, 1990; Konrad, 1995, 2001; Bocci i inni, 1998c.; Amato et al., 2000; Mawsouf et al., 2004; Bocci i in. 2009b).

 

Terapia ozonowa może być wdrożona w takich chorobach, jak:

  1. Choroby autoimmunologiczne ( reumatyczne, łuszczyca, Leśniowskiego - Crohna) (Menéndez et al., 1989; D'Ambrosi, 2002b; Esperanza, S., Ortellado, M., 2011; Molinari et i in., 2014).
  2. Otępienie starcze (Rodriguez i wsp., 1998).
  3. Choroby płuc (rozedma płuc, astma, przewlekła obturacyjna choroba płuc, idiopatyczne zwłóknienie płuc oraz zespół ostrej niewydolności układu oddechowego (Rosales Hernandez i inni, 2005; Bocci, 2007b).
  4. Choroby skóry (łuszczyca, zespół Stevensa-Johnsona i atopowezapalenie skóry) (Abeck i Plötz, 2008; Borrelli et al, 2008;. Izzo, 2008; Menendez et al, 2010.; Sirito, 2006; . Travagli i inni, 2009a, b, 2010c; Zamora i wsp., 2008;Re i wsp., 2015).
  5. Choroby nowotworowe  (Akbarov i wsp., 2010). 

Dane zostały zebrane i opublikowane przez World Federationof Ozone Therapy

Bibliografia ( niektóre artykuły i badania)

Akbarov, E.T., Navruzov, S.N., Abdujapparov, S.B., Islamov, H.D., 2010. 350 Target therapy and endoarterial chemotherapy with ozonotherapy in combined treatment of metastatic colorectal cancer. Eur J Cancer Suppl 8, 111. doi:10.1016/S1359-6349(10)72057-7 

Akey, D., and Walton, T. E., 1985, Liquid-phase study of ozone inactivation of Venezuelan Equine Encephalomyelitis virus, Appl. Environ. Microbiol. 50:882–886. 

Alexandre, A., Pentimalli, L., Rigobello, L., and Corò, N., 1999, Amaurosi fugax in un caso di discolisi cervicale mediante O2 –O3 . in L’Ozonoterapia nel 2000 (F. Ceccherelli, and F. Giron, Eds.), Edizioni Libreria Cortina, Torino, pp.141–144. 

Andreula, C. F., Simonetti, L., De Santis, F., Agati, R., Ricci, R., and Leonardi, M., 2003, Minimally invasive oxygen-ozone therapy for lumbar disk herniation, AJNR Am. J. Neuroradiol. 24:996–1000. 

Aris, R. M., Christian, D., Hearne, P. Q., Kerr, K., Finkbeiner, W. E., and Balmes, J. R., 1993, Ozone-induced airway inflammation in human subjects as determined by airway lavage and biopsy, Am. Rev. Respir. Dis. 148:1363–1372. 

Arvin, A. M., and Prober, C. G., 1997, Herpes simplex virus type 2 – a persistent problem, N. Engl. J. Med. 337:1158–1159. 

Aubourg, P., 1936, Colibacillose aigue, colibacillose cronique: ameliorations cliniques notables par un traitement d’ozone, Bull. Med. Paris 140:644–654. 52

 Aubourg, P., 1940, Ozon in der Chirurgie, Mem. Acad. Chir. 65:1183–1192. 

Badwey, J. A., and Karnovsky, M. L., 1980, Active oxygen species and the functions of phagocytic leukocytes, Annu. Rev. Biochem. 49:695–726. 

Baker, K. H., Hegarty, J. P., Redmond, B., Reed, N. A., and Herson, D. S., 2002, Effect of oxidizing disinfectants (chlorine, monochloramine, and ozone) on Helicobacter pylori, Appl. Environ. Microbiol. 68:981–984. 

Barakat, S., Seif-El Nasr, A., Ardel-Maksoud, N., El-Ebiary, F., Amer, H., Zaghloul, A., and Thabet, S., 2004, Induktion der angiogenese durch medizinisches ozon, in Ozon-Handbuch Grundlagen Pravention Therapie (R. Viebahn-Hansler, and H. G. Knoch, Eds.), Ecomed, Landsberg: in press. 

Barber, E., Menéndez, S., León, O. S., Barber, M. O., Merino, N., Calunga, J. L., Cruz, E., and Bocci, V., 1999, Prevention of renal injury after induction of ozone tolerance in rats submitted to warm ischaemia, Mediators Inflamm. 8:37–41. 

Belianin, Il., Abdullah, R. Iu., 2000, Use of soluble ozone in combined treatment of pulmonary
tuberculosis: lipid peroxidation and blood antioxidative defense system. Probl. Tuberk 3: 41–44. 

Berson, E. L., Remulla, J. F. C., Rosner, B., Sandberg, M. A., and Weigel-DiFranco, C., 1996, Evaluation of patients with retinitis pigmentosa receiving electric stimulation, ozonated blood, and ocular surgery in Cuba, Arch. Ophthalmol. 114:560–563. 

Bertoletti, A., and Izzo, A., 2006, Oxygen-ozone treatment of Buruli ulcer, Riv. Ital. Ossigeno Ozonoterapia 5:129–134. Bevers, R. F. M., 

Beyerle, 1996, cited by Null, 1996 (Ozone: a wide-spectrum realer, Penthouse Magazine January). Biedunkiewicz, B., Tylicki, L., Nieweglowski, T., Burakowski, S., and Rutkowski, B., 2004, Clinical efficacy of ozonated autohemotherapy in hemodialyzed patients with intermittent claudication: an oxygen-controlled study, Int. J. Artif. Organs 27:29–34. 

Bocchi, L., Cervelli, C., and Ferrata, P., 2000, L’ossigeno-ozono terapia nel trattamento delle patologie vertebrali lombari, in Proceedings: I Congresso IMOS, Italia, Siena, 2–4 novembre 2000, p. 15. 

Bocci, V., 1987a, May hyperbaric oxigenation be useful to patients with AIDS? J. Biol. Regul. Homeost. Agents 1:201. 

Bocci, V., 1992a, Ozonization of blood for the therapy of viral diseases and immunodeficiencies. A hypothesis, Med. Hypotheses 39:30–34. 

Bocci, V., 1994b, Autohaemotherapy after treatment of blood with ozone. A reappraisal, J. Int. Med. Res. 22:131–144. 

Bocci, V., 1996a, Does ozone therapy normalize the cellular redox balance? Med. Hypotheses 46:150–154. 

Bocci, V., 1996b, Ozone as a bioregulator. Pharmacology and toxicology of ozonetherapy today, J. Biol. Regul. Homeost. Agents 10:31–53. 

Bocci, V., 1996c, Ozone: a mixed blessing. New mechanisms of the action of ozone on blood cells make ozonated major autohaemotherapy (MAH) a rational approach, Forsch. Komplementärmed. 3:25–33.

 Bocci, V., 1998a, Ipotetici meccanismi di azione dell’ozono nel trattamento del conflitto discoradicolare, in Lombalgie e lombosciatalgie. Criteri di diagnosi e cura (F. Ceccherelli, and A. Ricciardi, Eds.), Edizioni Libreria Cortina, Torino, pp. 331–340.

 Bocci, V., 1998b, Is ozonetherapy therapeutic? Perspect. Biol. Med. 42:131–143. Bocci, V., 1998c, Ozonetherapy as a possible biological response modifier in cancer, Forsch. Komplementärmed. 5:54–60. 
Bocci, V., 1999a, Biological and clinical effects of ozone. Has ozonetherapy a future in medicine? Bocci, V., 1999b, Ozonetherapy as a complementary medical approach. Where are we and where do we need to go? in Proceedings of the International Ozone Symposium, 21 and 22 October 1999, Basel, Switzerland (IOA – EA3 G, Ed.),

Bauer Druck AG, Basel, pp. 353–374. Bocci, V., 2000, Ossigeno-ozono terapia, Casa Editrice Ambrosiana, Milano, pp. 1–324. Bocci, V., 2002, Oxygen-ozone therapy, a critical evaluation, Kluwer Academic Publischer, Dordrecht. 

Bocci, V., 2004, Ozone as Janus: this controversial gas can be either toxic or medically useful, Mediators Inflamm. 13:3–11. Bocci, V., 2006a, Scientific and medical aspects of ozone therapy, state of the art, Arch. Med. Res. 37:425–435. 

Bocci, V., 2006b, Is it true that ozone is always toxic? The end of the dogma, Toxicol. Appl. Pharmacol. 216:493–504. 

Bocci, V., 2007a, Can ozonetherapy be performed if the biochemistry of the process cannot be controlled? Arch. Med. Res. 38:584–585. 

Bocci, V., 2007 Può l’Ossigeno-Ozonoterapia migliorare la prognosi della bronco-pneumopatia cronica ostruttiva? Giorn. Ital. Mal. Tor. 61:434–446. 

Bocci, V., 2008a, Why orthodox medicine has not yet taken advantage of ozone therapy, Arch. Med. Res. 39:259–260. Bocci, V., 2008b, The failure of the ACCLAIM trial is due to an irrational technology, Int. J. Cardiol. DOI: 10 1016/ijcrd.2008.10.001. 

Bocci, V., 2008c, Non-specific immunomodulation in chronic heart failure, Lancet 371(9630):2083. 

Bocci, V., 2008d, Does ozone really “cure” cancer? Int. J. Cancer 123(5):1222. 

Bocci, V., 2011, Ozone. A new medical drug. Springer Dordrecht Heidelberg London New York 

Bocci, V., Aldinucci, C., Borrelli, E., Corradeschi, F., Diadori, A., Fanetti, G., and Valacchi, G., 2001a, Ozone in medicine, Ozone Sci. Eng. 23:207–217. 

Bocci, V., Aldinucci, C., Mosci, C., Carraro, F., and Valacchi, F., 2007a, Ozonation of human blood induces a remarkable upregulation of Heme Oxygenase-1, Mediators Inflamm. 2007:26785, DOI: 10.1155/2007/26785 

Bocci, V., Aldinucci, C., and Bianchi, L., 2005, The use of hydrogen peroxide as a medical drug, Riv. Ital. Ossigeno Ozonoterapia 4:30–39. 

Bocci, V., and Aldinucci, C., 2006, Biochemical modifications induced in human blood by oxygenation-ozonation, J. Biochem. Mol. Toxicol. 20:133–138. 


Bocci, V., Bianchi, L., Larin, A., 2003, The ozone enigma in medicine. The biochemical relationship between ozone and body fluids may account for its biological, therapeutic and toxic effects, Riv. Ital. Ossigeno Ozonoterapia 2:130-120. 

Bocci, V., and Brito, G. S., 2006, Ozone therapy in critical patients. Rationale of the therapy and proposed guidelines, Riv. Ital. Ossigeno Ozonoterapia 5:7–11. 

Bocci, V., and Di Paolo, N., 2004, Oxygenation-ozonization of blood during extracorporeal circulation (EBOO). Part III: a new medical approach, Ozone Sci. Eng. 26:195–205. 

Bocci, V., Di Paolo, N., 2009, Oxygen-ozone therapy in medicine: an update. Blood Purif. 28: 373–376. 
Bocci, V., and Paulesu, L., 1990, Studies on the biological effects of ozone 1. Induction of interferon gamma on human leucocytes, Haematologica 75:510–515. 

Bocci, V., Borrelli, E., Corradeschi, F., and Valacchi, G., 2000, Systemic effects after colorectal insufflation of oxygen-ozone in rabbits, Int. J. Med. Biol. Environ. 28:109–113. 

Bocci, V., Borrelli, E., Travagli, V., and Zanardi, I., 2009a, The ozone paradox: ozone is a strong oxidant as well as a medical drug, Medic. Res. Rev. 29:646–682. 

 Bocci, V., Borrelli, E., Travagli, V., and Zanardi, I., 2008, The term “liquid polyatomic oxygen” requires a correction but chemo and radiotherapy combined with ozone therapy may help cancer patients, Int. J. Ozone Ther. 7:63–65. 

Bocci, V., Travagli, V., and Zanardi, I., 2009e, Randomised, double-blinded, placebo-controlled,
clinical trial of ozone therapy as treatment of sudden sensorineural hearing loss, J. Laryngol.
Oto. 123(7):820. 

Bocci, V., Zanardi, I., Huijberts, M. S. P., Travagli, V., 2010c, Diabetes and chronic oxidative stress: a perspective based on the possible usefulness of ozone therapy. Diabetes Metab. Syndr. Clin. Res. Rev. doi: 10.1016/j.dsx.2010.05.014, in press. 

Bocci, V., Valacchi, G., Corradeschi, F., Aldinucci, C., Silvestri, S., Paccagnini, E., and Gerli, R., 1998a, Studies on the biological effects of ozone: 7. Generation of reactive oxygen species (ROS) after exposure of human blood to ozone, J. Biol. Regul. Homeost. Agents 12:67–75. 

Bocci, V., Valacchi, G., Corradeschi, F., and Fanetti, G., 1998b, Studies on the biological effects of ozone: 8. Effects on the total antioxidant status and on interleukin-8 production, Mediators Inflamm. 7:313–317. 

Bocci, V., Valacchi, G., Rossi, R., Giustarini, D., Paccagnini, E., Pucci, A. M., and Di Simplicio, P., 1999c, Studies on the biological effects of ozone: 9. Effects of ozone on human platelets, Platelets 10:110–116. 

Bocci, V., Venturi, G., Catucci, M., Valensin, P. E., and Zazzi, M., 1998c, Lack of efficacy of ozone therapy in HIV infection, Clin. Microbiol. Infec. 4:667–669. 

Bocci, V., Zanardi, I., Travagli, V., 2010b, Potentiality of oxygen-ozonetherapy to improve the health of aging people. Curr. Aging Sci. 3: in press Bentham Science Publisher. 

Borrelli, E., and Bocci, V., 2002, A novel therapeutic option for chronic fatigue syndrome and
fibromyalgia, Riv. Ital. Ossigeno Ozonoterapia 1:149–153. 

Bulent, U., Mehmet, Y., Nail, E. et al., 2010, Efficacy of hyperbaric oxygen therapy and medical
ozone therapy in experimental acute necrotizing pancreatitis, Pancreas 39:9–15.

Bulinin, V. I., Solod, N. V., and Moshurov, I. P., 1995, The first experience of chronic abscesses
and pleura emphyemas treatment by the method of ozonization, in The ozone in biology and
medicine. 2nd all Russian scientific-practical conference, September 6–8, 1995. Russian
association of ozonetherapy, Reshetnikovskaya street 2, Nizhni Novgorod, 603006 Russia, p.
20.

Bulmer, J., Bolton, A. E., and Pockley, A. G., 1997, Effect of combined heat, ozonation and
ultraviolet irradiation (VasoCare) on heat shock protein expression by peripheral blood
leukocyte populations, J. Biol. Regul. Homeost. Agents 11:104–110. 

Christian, D. L., Chen, L. L., Scannell, C. H., Ferrando, R. E., Welch, B. S., and Balmes, J. R.,
1998, Ozone-induced inflammation is attenuated with multiday exposure, Am. J. Respir. Crit.
Care Med. 158:532–537.

Cinnella, P., and Brayda-Bruno, M., 2001, La nostra esperienza nel trattamento dei conflitti disco-radicolari e delle radicolopatie post-chirurgiche con ossigeno-ozono terapia infiltrativa paravertebrale, Riv. Neuroradiol. 14:75–79. 

Diaz, S., Menendez, S., Eng, L., and Fernandez, I., 1995, No increase in sister chromatid exchanges and micronuclei frequencies in human lymphocytes exposed to ozone in vitro, in Proceedings Ozone in Medicine 12th World Congress of the International Ozone Association, 15th to 18th May 1995, Lille France (International Ozone Association, Ed.), Instaprint S.A., Tours, pp. 43–52. 

Diaz-Llera, S., Gonzalez-Hernandez, Y., Prieto-Gonzalez, E. A., and Azoy, A., 2002, Genotoxic effect of ozone in human peripheral blood leukocytes, Mutat. Res. 517:13–20 

Goldstein, B. D., and Balchum, O. J., 1967, Effect of ozone on lipid peroxidation in the red blood
cell, Proc. Soc. Exp. Biol. Med. 126:356–359.

Gomez, M., Espinosa, E., and Caplan, J. A., 1995, Application of medicinal ozone/oxygen in
patients with sickle cell anemia, Townsend Lett. Doctors January:48–52. 

Hernandez, F., Alvarez, I., Corcho, I., Gonzalez, M., 2004, Changes in glutathione antioxidant pathway components, HLA-DR and IgE in blood from asthma patients treated with ozone therapy, Proceedings of the 15th Ozone World Congress, London, UK. 11th-15th September 2001. Medical Therapy Conference (IOA 2001, Ed.). Ealing, London, UK: Speedprint MacMedia Ltd. pp.l31-141. 

Hernandez, F., Calunga, F., Turrent Figueras, J. et al., 2005, Ozone therapy effects on biomarkers and lung function in asthma, Arch. Med. Res. 36:549–554. 

Kraft, K., Stenkamp, E., Sachinidis, A., Seewald, S., and Vetter, H., 1998, Effect of autohemotherapy with ozone on cardiovascular risk factors in patients with mild hypertension, Perfusion11:216–219. 

León, O. S., Menéndez, S., Merino, N., Castillo, R., Sam, S., Pérez, L., Cruz, E., and Bocci, V., 1998, Ozone oxidative preconditioning: a protection against cellular damage by free radicals, Mediators Inflamm. 7:289–294. 

Miroshin, S. J., and Kontorshikova, C. N., 1995, The use of ozonetherapy technology in the treatment of modern war surgical trauma, in The ozone in biology and medicine. 2nd All Russian Scientific-Practical Conference, September 6–8, 1995. Russian association of ozonetherapy, Reshetnikovskaya street 2, Nizhni Novgorod, 603006 Russia, p. 16. 

Nakao, A., Sugimoto, R., Billiar, T. R., and McCurry, K. R., 2009a, Therapeutic antioxidant medical gas, J. Clin. Biochem. Nutr. 44:1–13 

Re, L., Martínez-Sánchez, G., Bordicchia, M., Malcangi, G., Pocognoli, A., Morales-Segura, MA., Rothchild, J. and Rojas, A., 2014, Is ozone pre-conditioning effect linked to Nrf2/EpRE activation pathway in vivo? A preliminary result. EJP, 742: 158–162. 

Riva Sanseverino, E., Meduri, R.A., Pizzino, A., Prantera, M., Martini, E., 1990. Effects of oxygen-ozone therapy on age-related degenerative retinal maculopathy. Panminerva Med 32, 77–84. 

Rodríguez, M.M., Menéndez, S., Devesa, E., Gonzáles, R., 1998b. [Ozone therapy in the treatment of senile dementia]. Rev CENIC Cienc Biol 29, 141–144.  100 

Rodríguez, M.M., Menéndez, S., García, J.R., Devesa, E., Cámbara, A., 1998c. [Ozone therapy in the treatment of old patients suffering from Parkinson’s syndromes]. Rev CENIC Cienc Biol 29, 149–152.  

Rokitansky, O., 1982, Klinik und Biochemie der Ozontherapie, Hospitalis 52:643–647.  

Rokitansky, O., Rokitansky, A., Steiner, J., Trubel, W., Viebahn, R., and Washüttl, J., 1981, Die Ozontherapie bei peripheren, arteriellen Durchblutungs-störungen; klinik, biochemische und blutgasanalytische Untersuchungen, in Wasser IOA, Ozon-Weltkongress, Berlin, pp. 53–75.  

Romero Valdes, A., Menendez Cepero, S., Gomez Moraleda, M., and Ley Pozo, J., 1993, Ozone therapy in the advanced stages of arteriosclerosis obliterans, Angiologia 45: 146–148.  

Romero, A. et al., 1988, La ozonoterapia en la aterosclerosis obliterante, CENIC Ciencias Biologicas 20:70–76.  

Schrope, M., 2000, Successes in fight to save ozone layer could close holes by 2050, Nature 408:627.  

Schulz, S., 1986, The role of ozone/oxygen in clindamycin-associated enterocolitis in the Djungarian hamster (Phodopus sungorus sungorus), Lab. Anim. 20:41–48.  

Sharma, Y. K., and Davis, K. R., 1997, The effects of ozone on antioxidant responses in plants, Free Radic. Biol. Med. 23:480–488.  

Siemsen, C.-H., 1995, Ozon-Anwendung bei akuten und chronischen Gelenkerkrankungen, in Ozon-Handbuch. Grundlagen. Prävention. Therapie (E. G. Beck, and R. Viebahn-Hänsler, Eds.), Ecomed, Landsberg, pp. V-9.2 1–V-9.2 14. 

Sirito, M. A., 2006, Oxygen-ozone therapy for local adipose deposits and oedematous fibrosclerotic panniculopathy. Riv. It Ossigeno Ozonoterapia 5:37–40. 

Tabaracci, G., 2001, L’ozonoterapia con tecnica “classica” intramuscolo paravertebrale, Riv. Neuroradiol. 14:67–70.  

Thiele, J. J., Traber, M. G., Tsang, K., Cross, C. E., and Packer, L., 1997a, In vivo exposure to ozone depletes vitamins C and E and induces lipid peroxidation in epidermal layers of murine skin, Free Radic. Biol. Med. 23:385–391.  

Thiele, J. J., Traber, M. T., Podda, M., Tsang, K., Cross, C. E., and Packer, L., 1997b, Ozone
 depletes tocopherols and tocotrienols topically applied to murine skin, FEBS Lett 401: 167–170. 

Thomson, A. J., Webb, D. J., Maxwell, S. R., and Grant, I. S., 2002, Oxygen therapy in acute medical care, BMJ 324:1406–1407.  

Vaughn, J. M., Chen, Y. S., Novotny, J. F., and Strout, D., 1990, Effects of ozone treatment on the infectivity of hepatitis A virus, Can. J. Microbiol. 36:557–560.  

Viebahn-Hänsler, R., 1999a, The use of ozone in medicine, ODREI Publishers, Iffezheim, pp. 1–148.  

Viebahn-Hänsler, R., 1999b, Einfluss auf den erythrozytenstoffwechsel, in Ozon-Handbuch. Grundlagen. Prävention. Therapie (E. G. Beck, and R. Viebahn-Hänsler, Eds.), Ecomed, Landsberg, pp. 1–15.  

Viebahn-Hänsler, R., Lell, B., and Kremsner, P. G., 2001, The effect of ozone on plasmodium falciparum-infected red blood cells, in Proceedings of the 15th Ozone World Congress, London, UK, 11th–15th September 2001, Medical Therapy Conference (IOA 2001, Ed.), Speedprint